Tuberculosis News and Research

Latest Tuberculosis News and Research

Wealthy nations launch vaccine purchase plan for diseases such as HIV/AIDS, TB, Malaria

Officials from a group of wealthy nations on Friday launched a $1.5 billion plan to provide and develop vaccines for diseases -- including HIV/AIDS, tuberculosis and malaria -- that largely affect developing countries, the New York Times reports.

13 Feb 2007

Determinants of disease presentation and outcome during cryptococcosis

CRNS and the Institut Pasteur conducted research in France on patients diagnosed with cryptococcosis which ranks second among fatal opportunistic infections in patients infected by HIV and who are profoundly immunosuppressed.

12 Feb 2007

Bush's budget proposal would allocate $5.4 billion for the "President's Emergency Plan for AIDS Relief"

President Bush on Monday released his $2.8 trillion fiscal year 2008 budget proposal, which would allocate $5.4 billion for the President's Emergency Plan for AIDS Relief, the Wall Street Journal reports.

7 Feb 2007

Institute of Materia Medica and TB Alliance partner to tackle tuberculosis

The Institute of Materia Medica (IMM), a member of the Chinese Academy of Medical Sciences, and the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of new TB drugs, today announced plans to pursue a joint research partnership to develop promising, novel anti-tuberculosis agents.

31 Jan 2007

Uganda plans to test 500,000 people for HIV annually by 2012

The Uganda AIDS Commission in a report released last week said it plans to test and counsel 500,000 people for HIV annually by 2012 and provide opportunistic infection prevention and treatment services to 90% of HIV-positive people in the country, Uganda's New Vision reports.

30 Jan 2007

Number of Parkinson's sufferers will double in next 25 years

The study highlights the significant challenge facing countries with rapidly growing economies, particularly in Asia, many of which are ill prepared to meet this impending public health threat.

29 Jan 2007

HIV/AIDS advocates call on Zimbabwe to address broad health care issues

Although some HIV/AIDS advocates in Zimbabwe are welcoming a recent pledge from the Zimbabwean government to provide increased access to antiretroviral drugs by the end of this year, they also are stressing the need to address a broader crisis in the country's health care system, VOA News reports.

29 Jan 2007

Advocates should focus on long-term strategy to fight HIV/AIDS

HIV/AIDS advocates should focus on developing a long-term strategy for the fight against the pandemic, Global Fund To Fight AIDS, Tuberculosis and Malaria Executive Director Richard Feachem said on Wednesday during a satellite meeting at the World Economic Forum in Davos, Switzerland, Reuters Health reports.

28 Jan 2007

Tuberculosis intervention program in Senegal improves patient outcomes

Patients with tuberculosis in the West African country of Senegal who participated in an intervention program that included improved communication with health personnel and community involvement had higher cure and treatment completion rates, according to a study in the January 24/31 issue of JAMA: The Journal of the American Medical Association.

23 Jan 2007

XDR-TB in South Africa

A team of medical ethics and public health experts say tough isolation measures, involuntary if need be, are justified to contain a deadly, contagious, drug-resistant strain of TB in South Africa and to prevent "a potentially explosive international health crisis."

23 Jan 2007

Sequella receives FDA fast track status for pulmonary tuberculosis drug

Sequella, Inc. has announced it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SQ109, the company's proprietary lead drug candidate for treatment of pulmonary tuberculosis (TB).

22 Jan 2007

More aid required for chronic conditions in developed world

In an article published in the January 18, 2007, issue of the New England Journal of Medicine, Gerard Anderson, PhD, professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, highlights the need for more international assistance to address chronic non-communicable conditions affecting people living in low and middle income countries.

18 Jan 2007

Race to accelerate tuberculosis drug development

Each year, tuberculosis kills nearly two million people while an estimated nine million develop the disease -- with the hardest-hit areas in AIDS-afflicted developing nations.

14 Jan 2007

New approach offers hope for an effective herpes vaccine

A researcher at Montana State University has called for an innovative, new approach in developing a vaccine against genital herpes.

10 Jan 2007

Global Fund Nomination Committee names nine candidates for Executive Director position

A nomination committee to name candidates for the executive director of the Global Fund To Fight AIDS, Tuberculosis and Malaria has narrowed the selection pool to nine people, the Boston Globe reports.

9 Jan 2007

Kenya's progress at reducing HIV/AIDS prevalence could be undermined by funding delays

Although Kenya has recorded a decrease in HIV/AIDS prevalence from 6.1% to 5.9% during the past year, the country's HIV/AIDS control efforts could be undermined by delays in funding disbursement and other challenges, the Lancet reports.

9 Jan 2007

Vaccine purchase plan for diseases auch as HIV/AIDS, tuberculosis, malaria needs political will, funding pledges

The advance market commitment plan aimed at funding the development of vaccines for diseases -- including HIV/AIDS, tuberculosis and malaria -- that largely affect developing countries is "a new way for partners in the private and public sectors to solve an old problem".

7 Jan 2007